“Antibiotic allergy delabeling prior to transplant is safe, is of high value and should definitely be considered in the pre-transplant evaluation period,” said Cosby Stone Jr., MD, MPH, assistant professor of Medicine in the Division of Allergy, Pulmonary and Critical Care Medicine.
Wade Iams, MD, MSCI, Travis Osterman, DO, MS, and colleagues report the case of a patient with metastatic ALK-rearranged NSCLC who was treated with the ALK inhibitor alectinib throughout two pregnancies.
The findings from human colon cancer specimens, culturing, and mouse models were reported last month by researchers at VUMC and Johns Hopkins University in the journal Cancer Discovery.
New research from Vanderbilt investigators suggests that clinicians should take a deeper dive into distinguishing EGFR mutations when prescribing targeted therapies for non-small-cell lung cancers.
The group used multiple single-cell technologies, unbiased machine learning, and traditional immunological approaches to track cellular and antibody responses in samples.
New partnership will develop a cadre of researchers and educators to lead cancer epidemiology research and training in Zambia.
The new multidisciplinary Fontan Clinic, led by Angela Weingarten, MD, will provide a coordinated care plan for children and teens.
VUMC's Robert Coffey, MD, is among authors of a new study reported in Frontiers in Oncology, that provides important insight into the tumor microenvironment
Inherited syndromes arising from rare genetic variants that cause cardiac arrhythmia (abnormal heart rhythm) are the most common cause of unexplained sudden death in people 15 to 30 years old. Yet it is difficult to distinguish benign (harmless) variants from those that are pathogenic.
